Aligos Therapeutics, Inc. (ALGS)
5.76
-0.45
(-7.25%)
USD |
NASDAQ |
Sep 08, 16:00
6.40
+0.64
(+11.11%)
After-Hours: 07:06
Aligos Therapeutics Debt to Equity Ratio : 0.1099 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1099 |
| March 31, 2026 | 0.1369 |
| December 31, 2025 | 0.098 |
| September 30, 2025 | 0.0844 |
| June 30, 2025 | 0.0675 |
| March 31, 2025 | 0.0676 |
| December 31, 2024 | -0.2891 |
| September 30, 2024 | 0.1823 |
| June 30, 2024 | 0.1463 |
| March 31, 2024 | 0.1753 |
| December 31, 2023 | 0.121 |
| September 30, 2023 | 0.2147 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.1783 |
| March 31, 2023 | 0.1412 |
| December 31, 2022 | 0.121 |
| September 30, 2022 | 0.1068 |
| June 30, 2022 | 0.0981 |
| March 31, 2022 | 0.094 |
| December 31, 2021 | 0.0782 |
| September 30, 2021 | 0.0572 |
| June 30, 2021 | 0.0742 |
| March 31, 2021 | 0.0659 |
| December 31, 2020 | 0.0591 |
| September 30, 2020 | -1.54 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 66.33M |
| Total Liabilities (Quarterly) | 34.44M |
| Shareholders Equity (Quarterly) | 31.88M |
| Current Ratio | 2.192 |
| Net Debt Paydown Yield | 2.43% |